|
|
||||||||
J Thorac Cardiovasc Surg 2006;132:1144-1149
© 2006 The American Association for Thoracic Surgery
Evolving Technology |
a Department of Cardiovascular Surgery, Le Bocage Hospital, Dijon, France
b Department of Pharmacology, Université de Montréal, Montreal, Quebec, Canada
c Department of Surgery, Montreal Heart Institute, Montreal, Quebec, Canada
d Department of Surgery, Texas Heart Institute, Houston, Tex.
Received for publication February 2, 2006; revisions received April 5, 2006; accepted for publication April 24, 2006. * Address for reprints: Louis P. Perrault, MD, PhD, Research Center, Montreal Heart Institute, 5000 Belanger St East, Montreal, Quebec H1T 1C8, Canada (Email: louis.perrault{at}icm-mhi.org).
| Abstract |
|---|
|
|
|---|
METHODS: Domestic swine were submitted to occlusion of the left anterior descending or right coronary artery using the poloxamer. The left and right internal thoracic arteries were used as grafts to perform coronary artery bypasses. Animals were humanely killed after 3 hours of perfusion (acute; n = 8) or 3 days (subacute; n = 6). The vascular reactivity of coronary artery was evaluated in response to serotonin and bradykinin. Histologic studies were performed to analyze cardiomyocyte necrosis and endothelial coverage.
RESULTS: The gel led to an occlusion of 7.8 ± 2.2 minutes. Concentration-response curves of occluded coronary segments showed no difference of endothelium-dependent relaxations in both operated groups (P < .05 vs control). Histologic studies demonstrated the absence of cardiomyocyte necrosis after coronary artery occlusion in the acute group; a small infarct zone was detected in 1 animal in the subacute group, resulting from an occlusion of the first diagonal branch. The endothelial layer coverage was preserved in both groups.
CONCLUSION: The poloxamer 407 represents a promising technique for obtaining hemostasis at the site of anastomosis during construction of bypasses during beating heart coronary artery surgery, without damage to the endothelium or ischemic consequence.
| Introduction |
|---|
|
|
|---|
The poloxamer 407 (P407; Pluromed Inc, Woburn, Mass) gel is biocompatible with cells and body fluids, nonthrombogenic, possesses low toxicity at high doses, and has weak immunogenic properties.8-10
It is soluble in aqueous solutions at low temperature and shows gelation behavior at body temperature. This reverse thermosensitive formulation has made P407 attractive for transdermal implants to control the delivery of various drugs11
and for temporary vascular occlusion because it solidifies only when it gets in contact with warm blood.12
The integrity of the microvascular reactivity has been evaluated after occlusion with P407,13
but its impact at the injection site in epicardial coronary arteries has not been evaluated. The objective of this study was to study the effects of P407 on endothelium-dependent vasorelaxation of epicardial coronary arteries after temporary occlusion during construction of coronary bypass grafts in a porcine model of OPCAB.
| Materials and Methods |
|---|
|
|
|---|
Swine were anesthetized by an intramuscular injection of a mixture of ketamine (20 mg/kg; Rogarsetic, Toronto, Ontario, Canada) and xylazine (2 mg/kg; Rompun, Cambridge, Ontario, Canada), and induction was achieved by mask ventilation with 2% isoflurane (Abbott Laboratories, Montreal, Quebec, Canada). Subsequently, the animals were intubated with a 6F cuffed endotracheal tube by an orotracheal approach with a straight blade. Artificial ventilation with an oxygen/air mixture was provided throughout the surgical intervention to maintain an arterial oxygen saturation of 95%, and a light anesthesia was induced by isoflurane 1% vol/vol. Respiratory control was maintained by frequent determinations of arterial blood gases and acidosis was balanced with 8.4% sodium bicarbonate (Abbott Laboratories, Quebec, Quebec, Canada). The electrocardiogram was recorded with 4 subcutaneous limb electrodes. Hair was shaved in the operative field and the skin was disinfected with a surgical scrub and a chlorexidine 0.5% solution. A catheter was placed in an auricular vein for administration of antibiotics at the beginning of the operation (Excenel 0.06 mL/kg; Pharmacia & Upjohn, Orangeville, Ontario, Canada) and for intravenous fluid infusion during the operation. Arterial cannulation was performed through the right femoral artery for blood pressure analysis and a rectal probe was used for monitoring the temperature.
Surgical Technique
After median sternotomy, the left or right internal thoracic artery was harvested as a pedicle to be used as a bypass graft to the left anterior descending (LAD) or the right coronary artery (RCA). After intravenous administration of 300 U/kg heparin (Leo Pharma, Ajax, Ontario, Canada), the pericardium was opened. The middle third of the LAD (distal to the first diagonal) or the proximal RCA was stabilized with the Octopus 4 tissue stabilizer (Medtronic, Inc, Minneapolis, Minn). After stabilization of the blood pressure, an incision 4 mm in length was performed on the LAD or RCA, while a light finger compression was applied 20 mm before the arteriotomy to avoid bleeding and to limit the gel diffusion beyond the proximal branches. P407 (20%, 250 µL) was then injected with a cardiac control syringe (Pluromed Inc, Woburn, Mass) in the proximal part of the LAD or RCA. The distal part of the catheter (made of polypropylene and styrene butadiene rubber: 13.8 mm in length, 0.9 mm and 1.5 mm for the internal and external diameters; Pluromed) is smooth with an olivary body extremity to render it atraumatic for the endothelium (Figure 1). After introduction of the catheter 15 mm into the coronary artery, the gel was rapidly injected with a progressive retracted movement to avoid uneven coating of the gel, which could compromise the efficacy of the occlusion. The left internal thoracic artery was anastomosed on the LAD or the right internal thoracic artery on the RCA with a polypropylene monofilament 7-0 suture. A new injection of gel or ice to liquefy the gel was required in some experiments (n = 5 in the acute group and n = 3 in the subacute group).
|
Subacute Group Protocol
After 3 hours of reperfusion, the chest was closed in multiple layers. An intradermal injection of an analgesic (Marcaine, 0.5 mg/mL; Astra Zeneca, Mississauga, Ontario, Canada) and an intramuscular injection of a second analgesic (buprenorphine, 0.6 mg; Reckitt Benckiser Healthcare (UK) Limited, Solihull, United Kingdom) were given at the end of the operation, and the animals (n = 12) were left to recover in temperature-controlled quarters. Swine received an intramuscular injection of the antibiotic ceftiofur sodium (Excenel, 0.06 mL/kg; Pharmacia & Upjohn, Orangeville, Ontario, Canada) for the 2 following days and were given an aspirin (325 mg) daily. Animals were humanely killed by exsanguination through a median sternotomy, using the previously described anesthetic technique. The heart was removed for vascular reactivity studies and histologic examination.
Coronary Harvesting
The heart was rapidly placed in a modified Krebs-bicarbonate solution (composition in mmol/L: NaCl 118.3, KCl 4.7, CaCl2 2.5, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25, ethylenediaminetetraacetic acid 0.026, dextrose 11.1; control solution) for harvesting of coronary arteries. The LAD, the left circumflex, and right epicardial coronary arteries were dissected free from adherent fat and connective tissue and were divided into rings 4 mm in length.
Vascular Reactivity Studies
Rings were then placed in organ chambers filled with the Krebs-bicarbonate solution (20 mL), maintained at 37°C, and oxygenated with a mixture of 95% oxygen/5% carbon dioxide. The rings were suspended between 2 metal stirrups, 1 connected to an isometric force transducer. Data were recorded on data acquisition software (IOS3; Emka Inc, Paris, France). After 30 minutes of stabilization, tension on rings was progressively increased to the optimal tension of its active length-tension curve (approximately 3.5g), as determined by measuring the contraction to potassium chloride (KCl, 30 mmol/L) at different levels of stretch. A maximal contraction was determined with KCl (60 mmol/L) and the baths were then washed. Rings were excluded if they failed to contract with KCl (exclusion rate of less than 5%). Afterward, all studies were performed in the presence of indomethacin (105 mol/L; to prevent the endogenous production of prostanoids), propranolol (107 mol/L; to prevent the activation of ß-adrenergic receptors), and ketanserin (106 mol/L; incubated 45 minutes before the addition of serotonin to antagonize smooth muscle cell serotonin 5-hydroxytryptamine [5-HT2] receptors). After 45 minutes of stabilization, prostaglandin F2
(range 2 x 106 to 105 mol/L) was added to achieve contraction, averaging 50% of the maximal contraction to KCl (60 mmol/L).
Endothelium-dependent Relaxations
The nitric oxidemediated relaxation pathway was studied by constructing concentration-response curves to serotonin (5-HT; 1010 to 105 mol/L, an agonist binding to endothelial 5-HT1D receptors coupled to Gi proteins) and to bradykinin (BK; 1012 to 106 mol/L, an agonist binding to endothelial B2 receptors coupled to Gq proteins leading to the release of nitric oxide and endothelium-derived hyperpolarizing factor). Since we have previously demonstrated that the 3 vessels types possess the same vascular reactivity, the left circumflex coronary artery was used as the control (data not shown).
Endothelium-independent Relaxations
Endothelium-independent relaxations were studied by the addition of a bolus of sodium nitroprusside (105 mol/L, an exogenous nitric oxide donor) to assess the maximal dilation.
Histologic Studies
Cardiomyocyte necrosis
Surgical biopsy specimens were taken from the anterior, posterior, and lateral free left ventricle and from the interventricular septum. They were then fixed in 10% buffered formalin, embedded in paraffin, and cut in 4-µm thick sections for histologic documentation. Each section was examined by an experienced cardiovascular pathologist blinded to the surgical procedure. Necrosis was determined using hematoxin phloxine safran.
Endothelial coverage
Segments of fresh coronary arteries were stained with silver nitrate to evaluate the endothelial cell coverage. Control and P407 rings were opened longitudinally to obtain strips 4 x 8 mm in size and were pinned to the bottom of a Petri dish. Samples were first fixed for 10 minutes with 0.1 mol/L phosphate buffer containing paraformaldehyde and glutaraldehyde. After a 1-minute wash with a sucrose solution, rings were exposed for 1 minute to 0.25% silver nitrate solution, followed by a second 1-minute wash and a second fixation period of 2 minutes. Incubation was then carried out for 3 hours in a sodium cacodylate solution under a spotlight. The stained samples were mounted whole on glass slides and the percent surface area covered by intact endothelium was then estimated by 2 blinded examiners with the aid of a microscope (magnification x250).
Drugs
All solutions were prepared daily; 5-HT creatinine sulfate (serotonin), BK, glutaraldehyde, indomethacin, ketanserin, paraformaldehyde. propranolol, prostaglandin F2
, silver nitrate, and sodium cacodylate were purchased from Sigma (Oakville, Ontario, Canada). Poloxamer 407 was provided by Pluromed (Lincoln, Mass).
Statistical analysis and data interpretation
Relaxations are expressed as a percentage of the maximal contraction to prostaglandin F2
(for 5-HT) or 5-HT (for BK), presented as mean ± standard error of the mean; n refers to the number of animal used. Analysis of variance studies were performed to compare concentration-response curve. The Student t test for paired/unpaired observations was used for the contractions.
| Results |
|---|
|
|
|---|
Subacute group
Six of 12 animals used in the subacute group died. In 4 cases, death was due to occlusion of the first diagonal branch during performance of the anastomosis. One animal died after having unstable hemodynamics before the beginning of surgery and 1 died of arrhythmia during the reperfusion. These pigs were thus excluded from data analysis. The occlusion time for the first injection was 7.2 ± 2.4 minutes and the dosage was 200 µL. A second injection was needed 3 times, and the quantity used was 130 ± 60 µL. The total dose was 380 ± 350 µL. The anastomosis time was 11.3 ± 2.7 minutes.
Vascular Reactivity Studies
Contractions
The amplitude of the contractions to KCl, to prostaglandin F2
, and to the concentration of prostaglandin F2
needed to achieve the target level of contraction to KCl were not statistically different between control and P407 epicardial coronary artery rings in both the acute and the subacute groups (Table 1).
|
|
|
Histologic Studies
Cardiomyocyte necrosis
In the myocardium vascularized by the LAD or RCA occluded with P407, there was no necrosis zone in the acute group. In the subacute group, a necrosis zone in the right ventricle was limited to the collateral ligature at the site of the anastomosis (1.5 x 1.8 cm) and to a zone in the left ventricle (4 x 3 cm); the latter remains unexplained because no atherothrombosis was found in the infarcted zone. Contraction bands were present in hearts from both groups, resulting from electrical cardioversion.
Endothelial coverage
P407-occluded vessels from both groups were compared with control strips. Histologic study of the endothelial cell coverage demonstrated preservation of the endothelial layer in P407 strips (100% of controls) (Figure 4).
|
| Discussion |
|---|
|
|
|---|
The polymer solution is injected as a soft gel at room temperature (
20°C) into the arteriotomy, and the rise in temperature leads to a stiff gel. The gel will start to dissolve in blood, and when the concentration of the polymer decreases below approximately 12.5 w%, it turns back into a liquid and quickly dilutes in blood to a concentration at which it cannot turn back into a gel at physiologic temperatures. Alternatively, cooling of the gel with ice or cold saline does liquefy the gel as the temperature falls below the gelation point. As a liquid, it quickly dilutes in blood and again there is no possibility for it to turn back into a gel at physiologic temperatures. P407 is not metabolized and is excreted renally with a half-life of approximately 25 hours.
The current study shows that the hemostatic technique involving intracoronary P407 to achieve a clear operative field does not cause endothelial dysfunction, demonstrated by the preservation of the epicardial coronary artery endothelium-dependent relaxations. This is supported by the absence of significant alterations of endothelial cell signaling pathway involving the Gi proteinmediated relaxations, as demonstrated by concentration-response curves to 5-HT, and the Gq proteinmediated pathway, as demonstrated by concentration-response curves to BK.
Boodhwani and colleagues13
have demonstrated that temporary occlusion of the LAD with P407 does not cause abnormalities in coronary flow during reperfusion, does not adversely affect regional myocardial function, and has no effect on endothelium-independent microvessel relaxation. Endothelium-dependent relaxation to adenosine diphosphate is preserved whereas response to substance P is mildly impaired, perhaps because of a local effect of the gel.13
In addition to coronary anastomosis, P407 effectively occluded renal and pulmonary arteries subjected to glue embolization.9
This study demonstrates that this agent has the potential to be used to protect a territory during polymer, particulate, or chemo-embolizations.
| Limitations |
|---|
|
|
|---|
In conclusion, the novel reversible thermosensitive gel P407 is safe and efficacious for temporary occlusion of the coronary vessel necessary for minimally invasive coronary artery operations. No negative effects were demonstrated on coronary endothelial function, as assessed by the preservation of the endothelial coverage and of endothelium-dependent relaxations.
| Acknowledgments |
|---|
| Footnotes |
|---|
* These authors contributed equally to the work. ![]()
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. Bottio, V. Tarzia, and G. Gerosa Temporary coronary artery occlusion during off-pump surgery and endothelial vessel dysfunction: Is it still an unresolved mystery? J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1397 - 1397. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |